Trial Profile
Comparing the Efficacy of Urinary and Recombinant hCG on Oocyte Maturity for Ovulation Induction in Assisted Reproductive Techniques: a Randomized Clinical Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Buserelin; Chorionic gonadotropin; Recombinant follicle-stimulating hormone
- Indications Infertility
- Focus Therapeutic Use
- 21 May 2013 Planned End Date changed from 1 Feb 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 18 Jan 2012 New trial record